Response to Jefford
J Natl Cancer Inst
.
2020 Mar 1;112(3):322-323.
doi: 10.1093/jnci/djz129.
Authors
Larissa Nekhlyudov
1
,
Lawrence N Shulman
2
,
Paul B Jacobsen
3
,
Michelle A Mollica
3
,
Ann M Geiger
3
,
Deborah K Mayer
4
5
Affiliations
1
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
2
Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
3
Healthcare Delivery Research Program, National Cancer Institute, Bethesda, MD.
4
UNC Lineberger Comprehensive Cancer Center and School of Nursing, University of North Carolina-Chapel Hill, NC.
5
Office of Cancer Survivorship, National Cancer Institute, Bethesda, MD.
PMID:
31233139
PMCID:
PMC7073931
DOI:
10.1093/jnci/djz129
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Neoplasms*
Research
Survivorship*